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tor and development of transgenic mice susceptible to EV71
may provide new insights into the molecular basis of EV71
infection in the near future.13th International Congress on Infectious Diseases Abstracts
Sarawak was carried out. Relevant epidemiologic informa-
tion from outbreaks in a number of countries in the Asia
Paciﬁc region was also abstracted.
Results: From Sarawak, we learned that since 1997, EV71
outbreaks have occurred every 3 years. The shapes of the
epidemiological curves are inﬂuenced by social factors such
as the media and people’s movements during big public hol-
idays. EV71 is not the only virus associated with HFMD, but
only EV71 causes very large outbreaks and resulting com-
plications. The genogroups of the EV71 isolated during each
major outbreak are genetically distinct from each other. The
transmission of EV71 in a susceptible cohort is extremely
rapid with only 4—6 weeks between ﬁrst identiﬁcation of an
EV71 case in our sentinel clinics to peaking.From Singapore
we know that HEV71 transmission occurs mainly in places
where preschool children congregate, and public health
measures to control the spread of this virus should focus
on these places. The 1998 Taiwan outbreak showed that
HFMD spreads easily through contact leading to mostly symp-
tomatic cases in children and mostly asymptomatic cases in
adults. Proper surveillance systems works, showing trends
and the current circulating viruses, and predicting coming
outbreaks.
Conclusion: We need to identify the reservoirs of EV71 in
the inter-epidemic periods, and develop simple rapid diag-
nostic tests that can be used in the districts to differentiate
EV71 from CA16.
doi:10.1016/j.ijid.2008.05.074
Emergence of EV71 in the Asia Paciﬁc in the Last Decade
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Human enterovirus 71 (HEV71, family Picornaviridae, genus
Enterovirus) was ﬁrst described in 1974 after it was iso-
lated from children with neurological infection in California,
USA. Following the report, the virus has been linked to
a broad spectrum of neurological manifestations including
encephalitis, aseptic meningitis and poliomyelitis-like paral-
ysis. The neurotrophic virus is also associated with hand,
foot and mouth disease (HFMD), a common febrile rash ill-
ness caused by enterovirus, particularly Coxsackievirus A16.
Over the last 10 years frequent explosive outbreaks of HEV71
neurological disease have occurred in many parts of Asia
with dozens of fatalities. Brief duration of illness, subtle
clinical presentation, very late appearance of ominous signs
and unexpected fulminant pulmonary oedema and cardiac
dysfunction in previously healthy children with HFMD are the
hallmarks of fatal cases of neurological HEV71 infection. As
a result, HFMD, which is normally considered an innocuous
illness, has become a diagnostic and management challenge
to many clinicians in Asia. Clinicians are faced with several
important clinical questions when they are presented with
a child with HFMD:
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. How to distinguish a child with HEV71 infection from
CVA16?
. How to recognize children at risk of neurological infec-
tion and fatal pulmonary oedema?
. What therapeutic measures are best for a critically ill
child with HEV71 infection?
The results of a number of clinical studies that attempted
o resolve these clinical questions will be reviewed and pre-
ented in this talk. We shall also present new data from a
rospective study in Sarawak spanning 3 distinct outbreaks
f HEV71.
oi:10.1016/j.ijid.2008.05.075
3.003
ouse and Non-human Primate Models for EV71 Disease
. Shimizu
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uring the ﬁnal stage of polio eradication in the Western
aciﬁc Region (WPR) in the late 1990s, there have been
arge outbreaks of hand, foot and mouth disease (HFMD)
ue to enterovirus 71 (EV71) associated with severe neu-
ological diseases. However, pathogenesis of EV71 infection
s still poorly understood, in part, due to limited animal
odels to study the neurovirulence of EV71. Immediately
fter the identiﬁcation of EV71 as one of most neurotropic
nteroviruses, a non-human primate model for EV71 dis-
ase had been established in the 1970s. In response to
ecent EV71-aassociated HFMD outbreaks in the WPR, we
ave extended this non-human primate model to study
he molecular basis of EV71 neurovirulence by using dif-
erent genotypes of ﬁeld EV71 isolates and genetically
odiﬁed EV71 mutants derived from infectious molecular
lones of EV71. By using the non-human primate model, we
ound that two major recent lineages of EV71 in the WPR,
enogroups B and C, are considered to be neurovirulent,
nd we have analyzed the attenuation determinants and
mmunogenicity of EV71 for further vaccine development.
he non-human primate model may provide more informa-
ion on EV71 pathogenesis than previous mouse infection
odels. However, mouse models, using young mice and/or
ouse-adapted EV71 variants, have been widely used to
tudy the in vivo phenotypes of EV71 due to the limited
vailability of non-human primates. Thus, we have recently
eveloped a novel mouse infection model using NOD/SCID
ice and a mouse adapted EV71 variant, and conﬁrmed the
resence of the same attenuation determinants of EV71 both
n non-human primate and mouse models. Although primate
nd mouse models would be still important to study the
athogenesis of EV71, identiﬁcation of the cellular recep-oi:10.1016/j.ijid.2008.05.076
